Tinzaparin sodium
亭扎肝素钠
Report date: 2026/05/20 20:02:01
NME
Base Information
Drug NameTinzaparin sodium
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1994/12/31
Country/Territory +[4]
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesFrance National Cancer InstituteNovo Nordisk A/SUniversity Of Southern California +[7]
Active IndicationsN/A
Inactive Indications +[7]